AUTL

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Autolus Therapeutics (AUTL) Earnings Date & Reports

Industry: @Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

AUTL is expected to report earnings to fall 33.55% to -20 cents per share on March 11

Autolus Therapeutics AUTL Stock Earnings Reports

Q4'24

Est.

$-0.21

Q3'24

Missed

by $0.10

Q2'24

Missed

by $0.03

Q1'24

Missed

by $0.16

Q4'23

Est.

$-0.44

The last earnings report on November 12 showed earnings per share of -31 cents, missing the estimate of -20 cents. With 2.28M shares outstanding, the current market capitalization sits at 610.75M.

View a ticker or compare two or three

Compare

AUTL

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For AUTL
(Try 14 days for Free)

Ad is loading...

A.I.Advisor

published price charts

A.I. Advisor

published General Information

General Information

a developer of cancer treatments

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

191 Wood Lane

Phone

+44 2038296230

Employees

471

Web

https://www.autolus.com